Neurocrine Biosciences, Inc.
US ˙ NasdaqGS ˙ US64125C1099

SecurityNBIX / Neurocrine Biosciences, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership47,568 shares
Latest Disclosed Value $ 6,267
Amalgamated Bank reports 1.70% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 47,568 shares of Neurocrine Biosciences, Inc. (US:NBIX) valued at $6,266,608 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 46,774 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 1.70% during the quarter. The current value of the position is $7,853,952 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,568 794 1.70 6 0.00 0.0480
2026-02-05 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 46,774 -1,135 -2.37 7 0.00 0.0479
2025-10-29 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,909 649 1.37 7 20.00 0.0480
2025-08-04 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,260 -459 -0.96 6 0.00 0.0459
2025-04-25 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 47,719 -1,895 -3.82 5 -16.67 0.0452
2025-02-04 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 49,614 -916 -1.81 7 20.00 0.0556
2024-10-30 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 50,530 -1,541 -2.96 6 -28.57 0.0480
2024-08-12 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 52,071 -3,098 -5.62 7 0.00 0.0611
2024-04-23 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 55,169 -12,814 -18.85 8 -12.50 0.0651
2024-02-06 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 67,983 -703 -1.02 9 14.29 0.0715
2023-11-08 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 68,686 -1,269 -1.81 8 16.67 0.0658
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,955 -1,959 -2.72 7 -14.29 0.0534
2023-05-02 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 71,914 -2,120 -2.86 7 -12.50 0.0620
2023-02-10 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 74,034 323 0.44 9 -99.90 0.0789
2022-11-09 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 73,711 2,089 2.92 7,829 12.13 0.0756
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 71,622 960 1.36 6,982 5.39 0.0651
2022-08-25 2022-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 70,662 14 0.02 6,625 10.10 0.0515
2022-06-30 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 70,662 14 6,625 0.0526
2022-02-15 2021-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 70,648 3,389 5.04 6,017 -6.73 0.0444
2022-02-15 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 70,648 3,389 6,017 0.0444
2021-10-29 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 67,259 -7,044 -9.48 6,451 -10.79 0.0545
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 74,303 56,987 329.10 7,231 329.39 0.0580
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,316 -1,290 -6.93 1,684 -5.55 0.0631
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,606 4 0.02 1,783 -0.34 0.0676
2020-10-30 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,602 -478 -2.51 1,789 -23.15 0.0778
2020-08-10 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,080 -4,798 -20.09 2,328 12.63 0.1077
2020-05-13 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,878 -375 -1.55 2,067 -20.71 0.0505
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,253 1,472 6.46 2,607 26.98 0.0480
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 22,781 2,789 13.95 2,053 21.62 0.0432
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,992 -412 -2.02 1,688 -6.12 0.0394
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,404 450 2.26 1,798 26.18 0.0436
2019-02-15 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,954 7,742 63.40 1,425 -5.06 0.0404
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,212 -8,611 -41.35 1,501 -26.64 0.0371
2018-07-18 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,823 1,911 10.10 2,046 30.48 0.0500
2018-05-22 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 18,912 1,428 8.17 1,568 15.55 0.0416
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,484 947 5.73 1,357 33.96 0.0367
2017-11-09 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,537 386 2.39 1,013 36.34 0.0315
2017-08-10 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,151 3,602 28.70 743 36.83 0.0244
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,549 -2,766 -18.06 543 -8.43 0.0270
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,315 1,585 11.54 593 -14.68 0.0268
2016-11-15 2016-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 13,730 1 0.01 695 4.98 0.0403
2016-08-16 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,729 4,735 52.65 662 85.96 0.0383
2016-05-11 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,994 785 9.56 356 -23.28 0.0347
2016-02-10 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,209 -745 -8.32 464 30.34 0.0572
2015-11-04 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,954 117 1.32 356 -15.64 0.0373
2015-07-10 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,837 375 4.43 422 25.60 0.0414
2015-04-22 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,462 8,462 336 0.0410
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.